Abstract
The use of modern technologies that enable the identification of transcripts expressed in brain nuclei involved in the control of neuroendocrine and metabolic function can immensely contribute to the identification of potential therapeutic targets in the fight against different metabolic disorders. The therapies currently available to treat anorexia nervosa, HIV-related lipodystrophy, cac…